ReviewCells2022

Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?

Nicolas Lanthier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.